Aprogen Medicines Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	May '25 May 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	201,128	216,365	234,315	399,707	335,573	374,121	Upgrade
Market Cap Growth	-7.66%	-7.66%	-41.38%	19.11%	-10.30%	-10.38%	Upgrade
Enterprise Value	552,626	601,077	577,535	792,820	588,371	548,883	Upgrade
Last Close Price	691.00	776.00	960.00	1716.00	5055.00	6135.00	Upgrade
PS Ratio	1.34	1.44	1.56	5.10	12.76	2.94	Upgrade
PB Ratio	0.46	0.49	0.56	0.87	-416.12	0.54	Upgrade
P/TBV Ratio	1.32	1.42	1.67	1.93	-	1.19	Upgrade
P/FCF Ratio	-	-	-	-	-	18.75	Upgrade
P/OCF Ratio	-	-	-	-	-	16.60	Upgrade
EV/Sales Ratio	3.68	4.00	3.84	10.12	22.38	4.32	Upgrade
EV/EBITDA Ratio	-	-	-	-	-	76.74	Upgrade
EV/EBIT Ratio	-	-	-	-	-	192.99	Upgrade
EV/FCF Ratio	-9.58	-	-	-	-	27.50	Upgrade
Debt / Equity Ratio	0.26	0.26	0.30	0.20	-560.94	0.12	Upgrade
Debt / EBITDA Ratio	-	-	-	-	-	11.98	Upgrade
Debt / FCF Ratio	-	-	-	-	-	4.29	Upgrade
Asset Turnover	0.25	0.25	0.25	0.14	0.04	0.17	Upgrade
Inventory Turnover	1.88	1.88	1.90	1.85	1.55	5.37	Upgrade
Quick Ratio	0.57	0.57	0.53	0.85	0.07	3.11	Upgrade
Current Ratio	1.19	1.19	1.15	2.35	0.24	5.11	Upgrade
Return on Equity (ROE)	-23.40%	-23.40%	-22.14%	-50.45%	-34.60%	-5.41%	Upgrade
Return on Assets (ROA)	-9.37%	-9.37%	-9.94%	-13.57%	-9.13%	0.24%	Upgrade
Return on Capital (ROIC)	-10.30%	-10.30%	-10.86%	-14.58%	-9.76%	0.26%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	-	-	0.40%	Upgrade
Earnings Yield	-28.88%	-26.84%	-23.74%	-24.68%	-27.99%	-12.43%	Upgrade
FCF Yield	-28.67%	-26.65%	-35.71%	-33.30%	-35.50%	5.33%	Upgrade
Buyback Yield / Dilution	-9.40%	-9.40%	-16.69%	-16.73%	-206.64%	-24.06%	Upgrade

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.